ѻý

Proteins Predict Dementia; Brain Function in Long COVID; Pregabalin Plus Opioids

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Neuro Break over a computer rendering of neurons.

Plasma analysis in middle-age adults identified risk in later life. (Science Translational Medicine)

A muscle-building supplement known as beta-hydroxy beta-methylbutyrate (HMB) improved spatial learning and memory in a disease. (Cell Reports)

In both mice and humans, was driven by a loss of neurons that normally project from the superior cervical ganglia into the pineal gland, which secretes melatonin. (Science)

Cognitive deficits were detectable nearly in some people with long COVID symptoms. (eClinicalMedicine)

Low amounts of of people with long COVID taste disturbance. (NEJM Evidence)

Older adults with mild cognitive impairment who received both had improved cognition, but some results were inconsistent. (JAMA Network Open)

Autism spectrum disorder was diagnosed in 3.5% to 5.3% of children in Puerto Rico with evidence of exposure. (Morbidity and Mortality Weekly Report)

People prescribed the anti-convulsant medication had a 42% greater risk of developing opioid use disorder or opioid overdose than those prescribed only opioids, Epic Research data showed.

Abnormal was seen in visual snow syndrome and migraine with aura. (Annals of Neurology)

Nearly 1.4 million were made annually by people with Alzheimer's or related dementia, data from the 2016-2019 National Hospital Ambulatory Medical Care Survey showed. (JAMA Neurology)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.